What Makes Us Different
Malvern Consulting Group brings decades of clinical, CMC, regulatory, commercial, and capital-markets experience to every engagement. We help biotech teams move faster, avoid costly delays, and communicate with clarity — whether you’re preparing a regulatory milestone or raising your next round of funding.
Our Expertise:
- Rapid Clinical Development Strategy
- Accelerated CMC & Regulatory Execution
- Commercial Strategy & Launch Readiness
- Investor Presentations & Fundraising Support
- Integrated Clinical–CMC–Commercial Alignment
- Hands-On Program & Alliance Management
Our Services
Who We Are
Malvern Consulting Group is a boutique life-sciences consulting firm based outside Philadelphia. Our senior consultants have led programs on both clinical and commercial sides of the industry — and have worked directly with executive teams, investors, and boards to shape strategy and fund advancement. We operate with the speed, flexibility, and cross-functional expertise emerging biopharma companies need to stay competitive.
Our Operating Model
- Nimble and Fast: Rapid assessments and accelerated delivery.
- Senior Only: Every engagement is led and executed by experienced professionals.
- Integrated: Clinical, CMC, regulatory, commercial, and investor alignment from the start.
- Action-Oriented: Strategy paired with hands-on execution.
Questions? Get The Answers Here
What types of biopharma companies does Malvern typically work with?
- We primarily support emerging and growth-stage biopharma organizations that need fast, senior-level guidance across clinical, CMC, regulatory, commercial, and investor-facing functions. Many of our clients operate with lean internal teams and require cross-functional expertise to keep programs moving and milestones on track.
How is Malvern different from larger consulting firms?
- Every engagement is led and executed by senior professionals — no handoffs, no junior teams, and no delays. Our model is built around speed, integrated strategy, and investor awareness, allowing clients to make decisions quickly and communicate with clarity to regulators, partners, and the capital markets.
Can Malvern support both scientific strategy and investor messaging?
- Yes. We combine scientific and operational expertise with the ability to translate complex data into investor-ready narratives. This includes pitch decks, milestone planning, competitive positioning, and preparation for board or fundraising meetings.
Do you provide hands-on execution, or only high-level strategy?
- We do both. In addition to strategic planning, we offer hands-on program and alliance management, CRO and CDMO oversight, regulatory meeting preparation, CMC roadmap development, commercial groundwork, and other executional support required to keep programs and timelines moving.
How quickly can Malvern begin working with a new client?
- Because our model is senior-only and highly flexible, we are able to begin engagements quickly — often within days. We conduct a rapid assessment, identify priority gaps, and mobilize fast to support upcoming milestones, regulatory interactions, or fundraising needs.